Medication use in equestrian sport raises complex welfare questions. Understanding the difference between therapeutic treatment and performance-enhancing doping is essential for welfare advocacy.
Medication in equestrian sport exists on a spectrum from clearly therapeutic to clearly welfare-abusing, with a contested middle ground of permitted substances that reduce pain in ways that may allow horses to compete beyond their welfare limits. The principle that horses cannot consent to competition means that human responsibility for ensuring they are not in pain during competition is paramount. Pain-masking substances that enable horses to compete while suffering are welfare violations regardless of their regulatory status. Welfare-centred doping control focuses not just on prohibited substances but on the welfare outcome: is this horse able to compete without pain? Testing regimes and veterinary inspection that assess welfare outcomes alongside substance presence represent a more comprehensive welfare approach than substance prohibition alone.